{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:42Z","timestamp":1786979622928,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,11,23]],"date-time":"2013-11-23T00:00:00Z","timestamp":1385164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00115-013-3947-9","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T07:36:39Z","timestamp":1385019399000},"page":"1467-1472","source":"Crossref","is-referenced-by-count":20,"title":["Diagnose und Therapie des Late-onset-Morbus-Pompe","Diagnosis and therapy of late onset Pompe disease"],"prefix":"10.1007","volume":"84","author":[{"given":"A.","family":"Sch\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kornblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Deschauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vorgerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Schrank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Lukacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gl\u00e4ser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Pl\u00f6ckinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Schoser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,23]]},"reference":[{"key":"3947_CR1","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00415-011-6293-5","volume":"259","author":"Angelini","year":"2012","unstructured":"Angelini C, Semplicini C, Ravaglia S et al (2012) Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. J Neurol 259:952\u2013958","journal-title":"J Neurol"},{"key":"3947_CR2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.33588\/rn.5408.2012088","volume":"54","author":"Barba-Romero","year":"2012","unstructured":"Barba-Romero MA, Barrot E, Bautista-Lorite J et al (2012) Clinical guidelines for late-onset Pompe disease. Rev Neurol 54:497\u2013507","journal-title":"Rev Neurol"},{"key":"3947_CR3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1212\/WNL.0b013e31818da91e","volume":"71","author":"Bembi","year":"2008","unstructured":"Bembi B, Cerini E, Danesino C et al (2008) Diagnosis of glycogenosis type II. Neurology 71:S4\u2013S11","journal-title":"Neurology"},{"key":"3947_CR4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10545-010-9201-8","volume":"33","author":"Bembi","year":"2010","unstructured":"Bembi B, Pisa FE, Confalonieri M et al (2010) Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis 33:727\u2013735","journal-title":"J Inherit Metab Dis"},{"key":"3947_CR5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mus.22329","volume":"45","author":"Cupler","year":"2012","unstructured":"Cupler EJ, Berger KI, Leshner RT et al (2012) Consensus treatment recommendations for late-onset Pompe disease. Muscle Nerve 45:319\u2013333","journal-title":"Muscle Nerve"},{"key":"3947_CR6","unstructured":"Disease; Guidelines for the Investigation and Management of Late Onset Acid Maltase Deficieny UK. http:\/\/www.specialisedservices.nhs.uk\/library\/23\/Guidelines_for_Lat"},{"key":"3947_CR7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1164\/rccm.200307-885ST","volume":"170","author":"Finder","year":"2004","unstructured":"Finder JD, Birnkrant D, Carl J et al (2004) Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 170:456\u2013465","journal-title":"Am J Respir Crit Care Med"},{"key":"3947_CR8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/GIM.0b013e3182142966","volume":"13","author":"Forsha","year":"2011","unstructured":"Forsha D, Li JS, Smith PB et al (2011) Late-onset treatment study investigators: cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy. Genet Med 13:625\u2013631","journal-title":"Genet Med"},{"key":"3947_CR9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awh384","volume":"128","author":"Hagemans","year":"2005","unstructured":"Hagemans ML, Winkel LP, Van Doorn PA et al (2005) Clinical manifestation and natural course of late-onset Pompe\u2019s disease in 54 Dutch patients. Brain 128:671\u2013677","journal-title":"Brain"},{"key":"3947_CR10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.nmd.2007.03.006","volume":"17","author":"Hagemans","year":"2007","unstructured":"Hagemans ML, Lafor\u00eat P, Hop WJ et al (2007) Impact of late-onset Pompe disease on participation in daily life activities: evaluation of the Rotterdam Handicap Scale. Neuromuscul Disord 17:537\u2013543","journal-title":"Neuromuscul Disord"},{"key":"3947_CR11","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jpeds.2009.07.006","volume":"155","author":"Llerena","year":"2009","unstructured":"Llerena JC Jr, Horovitz DM, Marie SK et al (2009) The Brazilian consensus on the management of Pompe disease. J Pediatr 155:S47\u2013S56","journal-title":"J Pediatr"},{"key":"3947_CR12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0140-6736(11)61266-X","volume":"379","author":"Mechtler","year":"2012","unstructured":"Mechtler TP, Stary S, Metz TF et al (2012) Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria. Lancet 379:335\u2013341","journal-title":"Lancet"},{"key":"3947_CR13","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/WNL.57.7.1290","volume":"57","author":"Mellies","year":"2001","unstructured":"Mellies U, Ragette R, Schwake C et al (2001) Sleep-disordered breathing and respiratory failure in acid maltase deficiency. Neurology 57:1290\u20131295","journal-title":"Neurology"},{"key":"3947_CR14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nmd.2007.06.002","volume":"17","author":"M\u00fcller-Felber","year":"2007","unstructured":"M\u00fcller-Felber W, Horvath R, Gempel K et al (2007) Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord 17:698\u2013706","journal-title":"Neuromuscul Disord"},{"key":"3947_CR15","unstructured":"National guidelines on the diagnosis and treatment of Pompe disease in Belgium. http:\/\/www.boks.be\/site\/index.php\/content\/view\/42\/50\/lang,nl\/"},{"key":"3947_CR16","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2174\/138920111795542606","volume":"12","author":"Parenti","year":"2011","unstructured":"Parenti G, Andria G (2011) Pompe disease: from new views on pathophysiology to innovative therapeutic strategies. Curr Pharm Biotechnol 12:902\u2013915","journal-title":"Curr Pharm Biotechnol"},{"key":"3947_CR17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2012.04.027","volume":"106","author":"Patel","year":"2012","unstructured":"Patel TT, Banugaria SG, Case LE et al (2012) The impact of antibodies in late-onset Pompe disease: a case series and literature review. Mol Genet Metab 106:301\u2013309","journal-title":"Mol Genet Metab"},{"key":"3947_CR18","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1183\/09031936.05.00020005","volume":"26","author":"Pellegrini","year":"2005","unstructured":"Pellegrini N, Laforet P, Orlikowski D et al (2005) Respiratory insufficiency and limb muscle weakness in adults with Pompe\u2019s disease. Eur Respir J 26:1024\u20131031","journal-title":"Eur Respir J"},{"key":"3947_CR19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10545-012-9451-8","volume":"35","author":"Regnery","year":"2012","unstructured":"Regnery C, Kornblum C, Hanisch F et al (2012) 36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy. J Inherit Metab Dis 35:837\u2013845","journal-title":"J Inherit Metab Dis"},{"key":"3947_CR20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ymgme.2011.08.011","volume":"104","author":"Roberts","year":"2011","unstructured":"Roberts M, Kishnani PS, Ploeg AT van der et al (2011) The prevalence and impact of scoliosis in Pompe disease: lessons learned from the Pompe Registry. Mol Genet Metab 104:574\u2013582","journal-title":"Mol Genet Metab"},{"key":"3947_CR21","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s00415-010-5618-0","volume":"257","author":"Sacconi","year":"2010","unstructured":"Sacconi S, Bocquet JD, Chanalet S et al (2010) Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease. J Neurol 257:1730\u20131733","journal-title":"J Neurol"},{"key":"3947_CR22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2990.2007.00839.x","volume":"33","author":"Schoser","year":"2007","unstructured":"Schoser B, M\u00fcller-H\u00f6cker J, Gempel K et al (2007) Glycogen storage disease type 2: clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol 33:544\u2013559","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3947_CR23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajmg.c.31322","volume":"160","author":"Sch\u00fcller","year":"2012","unstructured":"Sch\u00fcller A, Wenninger S, Strigl-Pill N, Schoser B (2012) Toward deconstructing the phenotype of late-onset Pompe disease. Am J Med Genet C Semin Med Genet 160:80\u201388","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"3947_CR24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mus.20665","volume":"35","author":"Slonim","year":"2000","unstructured":"Slonim AE, Bulone L, Goldberg T et al (2000) Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 35:70\u201377","journal-title":"Muscle Nerve"},{"key":"3947_CR25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00415-009-5275-3","volume":"257","author":"Strothotte","year":"2010","unstructured":"Strothotte S, Strigl-Pill N, Grunert B et al (2010) Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol 257:91\u201397","journal-title":"J Neurol"},{"key":"3947_CR26","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","volume":"260","author":"Toscano","year":"2013","unstructured":"Toscano A, Schoser B (2013) Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol 260:951\u2013959","journal-title":"J Neurol"},{"key":"3947_CR27","first-page":"396","volume":"362","author":"Ploeg","year":"2010","unstructured":"Ploeg AT van der, Clemens PR, Corzo D et al (2010) A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. N Engl J Med 362:396\u2013406","journal-title":"N Engl J Med"},{"key":"3947_CR28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.nmd.2010.07.277","volume":"20","author":"Capelle","year":"2010","unstructured":"Capelle CI van, Beek NA van der, Hagemans ML et al (2010) Effect of enzyme therapy in juvenile patients with Pompe disease: a three-year open-label study. Neuromuscul Disord 20:775\u2013782","journal-title":"Neuromuscul Disord"},{"key":"3947_CR29","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","volume":"372","author":"Ploeg","year":"2008","unstructured":"Ploeg AT van der, Reuser AJ (2008) Pompe\u2019s disease. Lancet 372:1342\u20131345","journal-title":"Lancet"},{"key":"3947_CR30","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","volume":"252","author":"Winkel","year":"2005","unstructured":"Winkel LP, Hagemans ML, Doorn PA van et al (2005) The natural course of non-classic Pompe\u2019s disease; a review of 225 published cases. J Neurol 252:875\u2013884","journal-title":"J Neurol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-013-3947-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-013-3947-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-013-3947-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T18:41:49Z","timestamp":1746038509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-013-3947-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,23]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3947"],"URL":"https:\/\/doi.org\/10.1007\/s00115-013-3947-9","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,23]]}}}